Johnston Richard A, Van Scott Michael R, Kommineni Choudari, Millecchia Lyndell L, Dortch-Carnes Juanita, Fedan Jeffrey S
Department of Pharmacology and Toxicology, Robert C. Byrd Health Sciences Center of West Virginia University, Morgantown, West Virginia, USA.
J Pharmacol Exp Ther. 2004 Jan;308(1):37-46. doi: 10.1124/jpet.103.051672. Epub 2003 Oct 17.
We investigated the in vivo and in vitro effects of lipopolysaccharide (LPS) treatment (4 mg/kg i.p.) on guinea pig airway smooth muscle reactivity and epithelial bioelectric responses to methacholine (MCh) and hyperosmolarity. Hyperosmolar challenge of the epithelium releases epithelium-derived relaxing factor (EpDRF). Using a two-chamber, whole body plethysmograph 18 h post-treatment, animals treated with LPS were hyporeactive to inhaled MCh aerosol. This could involve an increase in the release and/or actions of EpDRF, because LPS treatment enhanced EpDRF-induced smooth muscle relaxation in vitro in the isolated perfused trachea apparatus. In isolated perfused tracheas the basal transepithelial potential difference (Vt) was increased after LPS treatment. The increase in Vt was inhibited by amiloride and indomethacin. Concentration-response curves for changes in Vt in response to serosally and mucosally applied MCh were biphasic (hyperpolarization, <3 x 10(-7)M; depolarization, >3 x 10(-7)M); MCh was more potent when applied serosally. The hyperpolarization response to MCh, but not the depolarization response, was potentiated after LPS treatment. In both treatment groups, mucosally applied hyperosmolar solution (using added NaCl) depolarized the epithelium; this response was greater in tracheas from LPS-treated animals. The results of this study indicate that airway hyporeactivity in vivo after LPS treatment is accompanied by an increase in the release and/or actions of EpDRF in vitro. These changes may involve LPS-induced bioelectric alterations in the epithelium.
我们研究了腹腔注射脂多糖(LPS,4mg/kg)对豚鼠气道平滑肌反应性以及上皮对乙酰甲胆碱(MCh)和高渗刺激的生物电反应的体内和体外影响。上皮的高渗刺激可释放上皮源性舒张因子(EpDRF)。在治疗后18小时,使用双腔全身体积描记器,接受LPS治疗的动物对吸入的MCh气雾剂反应性降低。这可能涉及EpDRF释放和/或作用的增加,因为LPS治疗增强了体外分离灌注气管装置中EpDRF诱导的平滑肌舒张。在分离灌注的气管中,LPS治疗后基础跨上皮电位差(Vt)增加。Vt的增加被氨氯吡咪和吲哚美辛抑制。响应于浆膜侧和粘膜侧应用MCh的Vt变化的浓度 - 反应曲线是双相的(超极化,<3×10(-7)M;去极化,>3×10(-7)M);浆膜侧应用时MCh更有效。LPS治疗后,对MCh的超极化反应增强,但去极化反应未增强。在两个治疗组中,粘膜侧应用高渗溶液(添加NaCl)使上皮去极化;这种反应在LPS治疗动物的气管中更大。本研究结果表明,LPS治疗后体内气道反应性降低伴随着体外EpDRF释放和/或作用的增加。这些变化可能涉及LPS诱导的上皮生物电改变。